Researchers from IDIBELL and the UB present a new tool to study the post-transcriptional regulation of gene expression at single-cell resolution
SCALPEL: analyzing gene expression in high resolution Read More »
The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.
IDIBELL and the Bellvitge Hospital will promote a new project to improve immune tolerance in kidney transplant patients and reduce the risk of rejection.
31% of patients already had symptoms of cognitive impairment at the time of lung cancer diagnosis, underscoring the importance of monitoring this disorder to improve patients’ quality of life.
Researchers from IDIBELL-CSIC have developed an innovative therapy, based on the use of guided missiles against weak points of pancreatic tumours.
Guided missiles against tumour cells, a possible therapy against pancreatic cancer Read More »
Massive exposure to tobacco-related images can influence young people’s perceptions of tobacco use, normalizing it and increasing the risk of them starting to smoke.
Study reveals worrying exposure of young people to tobacco-related TV content Read More »
Researchers generate a patch of myocardial tissue by 3D bioprinting that, for the first time, can grow, mature and survive in the long term after being implanted into a host
IDIBELL researchers generate heart tissue by 3D bioprinting for the first time Read More »
Embryonic cells have been filmed for the first time eliminating bacteria before the immune system forms.
This past Saturday, June 14, science coloured the Bellvitge neighbourhood thanks to Sinergia, the open doors of IDIBELL and the Bellvitge health campus with the support of the City Council of L’Hospitalet del Llobregat. It did so with workshops, organised activities, games, and music to get closer to the residents of the city, inviting them
Science and the street meet in Sinergia, the IDIBELL open day Read More »
Sinergia will open access to the cutting-edge biomedical research carried out by the Bellvitge Biomedical Research Institute (IDIBELL) in L’Hospitalet
From the lab to the hood: Sinergia 2025 brings IDIBELL research closer to the city Read More »
